What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

Polaryx Therapeutics, Inc. PLYX Change in Accrued Liabilities

Praxis Precision Medicines, Inc.PRAX

-$17.39M-110%

Guidewire SoftwareGWRE

-$69.63M-23.1%

SyscoSYY

$61M+175%

Texas RoadhouseTXRH

-$1.81M+80.3%

TeraWulfWULF

$52.55M+1,106%

Core Scientific, Inc.CORZ

-$16.36M-703%

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

EPS (diluted)-$0.05+54.5%

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Operating cash flow-$2.1M-191%

Market cap$115.64M—

Return on equity-1,209.8%—

Current ratio3.5×—

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.

The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Polaryx Therapeutics, Inc. 's change in accrued liabilities?: Polaryx Therapeutics, Inc. (PLYX) reported change in accrued liabilities of -$16.5K in Q4 2025.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.